Karpus Investment Management’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,870
Closed -$15.1M 451
2022
Q3
$15.1M Sell
5,870
-21
-0.4% -$53.7K 0.53% 41
2022
Q2
$15M Sell
5,891
-27
-0.5% -$68.4K 0.5% 35
2022
Q1
$15M Sell
5,918
-251
-4% -$632K 0.46% 46
2021
Q4
$15.5M Buy
6,169
+531
+9% +$1.33M 0.45% 58
2021
Q3
$14.2M Sell
5,638
-22
-0.4% -$54.5K 0.42% 65
2021
Q2
$14M Buy
5,660
+3,142
+125% +$7.77M 0.42% 63
2021
Q1
$6.18M Buy
+2,518
New +$6.17M 0.19% 117

Other funds holding ICU

Karpus Investment Management's ICU Position: Q4 2022 in Review

Karpus Investment Management sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 5,870 shares — an estimated $15.1M sold.

Karpus Investment Management first reported a position in ICU in Q1 2021 and held it in 7 quarters. The position peaked at $15.5M in Q4 2021. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

  • Karpus Investment Management reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
  • Karpus Investment Management sold 5,870 SeaStar Medical shares in Q4 2022, an estimated $15.1M.
  • Karpus Investment Management first reported a position in SeaStar Medical in Q1 2021 and held it in 7 quarters.
  • Karpus Investment Management's SeaStar Medical position peaked at $15.5M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on Karpus Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.